Correvio Pharma Corp. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Correvio Pharma Corp. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of CAD 8.41 million as of 2014-12-31, per its 40-F filed 2015-03-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2015-03-27
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 8.41M CAD.
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 4.40M CAD.
- 2012-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 67.00K CAD; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed 65.00K CAD.
- 2011-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 0.00 CAD.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2014-12-31 | 8.41M CAD 40-F · filed 2015-03-27 | |
| 2013-12-31 | 4.40M CAD 40-F · filed 2015-03-27 | |
| 2012-12-31 | 67.00K CAD 40-F · filed 2015-03-27 | 65.00K CAD 20-F/A · filed 2013-04-18 |
| 2011-12-31 | 0.00 CAD 40-F/A · filed 2014-04-30 | |
| 2010-12-31 | 4.53M CAD 20-F/A · filed 2013-04-18 |